Ignite Creation Date:
2025-12-24 @ 6:57 PM
Ignite Modification Date:
2025-12-31 @ 4:36 PM
Study NCT ID:
NCT00086957
Status:
COMPLETED
Last Update Posted:
2017-02-27
First Post:
2004-07-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Sponsor:
City of Hope Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-01
Start Date Type:
None
Primary Completion Date:
2015-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-08
Completion Date Type:
ACTUAL
First Submit Date:
2004-07-08
First Submit QC Date:
None
Study First Post Date:
2004-07-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-11-04
Results First Submit QC Date:
None
Results First Post Date:
2017-02-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-06
Last Update Post Date:
2017-02-27
Last Update Post Date Type:
ACTUAL